Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

An “F” for pharma at med schools

Executive Summary

Most U.S. medical schools are granting too much access to pharmaceutical representatives, according to a scorecard released by the American Medical Student Association. The "AMSA 2007 PharmFree Scorecard" is part of the association's PharmFree Campaign to remove industry influence from medical practice. "A" grades - given to Stanford, UC Davis, University of Pennsylvania, University of Michigan and Yale - were given to schools with a "comprehensive policy that restricts pharmaceutical representatives' access to both the medical school campus and the Academic Medical Center." Eight schools received a "B," 23 a "C+," 13 a "C," 8 a "C-," and 19 a "D," and 40 schools were given "F" grades...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS048371

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel